Sustainable Development Impacts of Investment Incentives

The document examines Singapore's strategic shift toward a knowledge-based economy by developing a globally competitive biomedical sciences (BMS) sector to mitigate the decline of the electronics industry. It details the use of financial incentives, infrastructure like the Biopolis hub, and R&D subsidies to attract multinational corporations (MNCs) and foster a high-value-added industry. While the strategy successfully increased foreign direct investment (FDI) and high-quality employment, the report notes limited spillover effects for domestic small and medium-sized firms and suggests focusing on niche disease areas and ASEAN regional integration for future growth.

• Singapore implemented a multifaceted strategy to develop a biomedical sciences (BMS) sector as a niche for human healthcare, aiming to offset the decline of the electronics industry which previously accounted for nearly half of manufacturing output.
• The government invested over SGD 3 billion (USD 2.1 billion) in the BMS initiative starting in 2000, including a subsequent SGD 1.5 billion (USD 1 billion) in 2006 to enhance translational and clinical sciences capabilities.
• The Biopolis hub, opened in 2003 with a cost of SGD 295 million (USD 210 million), serves as a central R&D cluster housing 2,000 researchers and international centers to catalyze innovation.
• Investment incentives, including tax exemptions and infrastructure, successfully attracted major pharmaceutical MNCs such as GlaxoSmithKline, Pfizer, Merck, and Novartis, leading the sector to capture 41% of total manufacturing FDI by 2007.
• Employment in the biomedical sector grew from 5,880 people in 2000 to 12,450 by 2008, though the sector offers fewer total jobs than the electronics industry it replaces.
• The biomedical sector demonstrates exceptionally high value added per worker at SGD 900,000 (USD 641,000), significantly exceeding the manufacturing average of SGD 174,000 (USD 124,000).
• There is a perceived imbalance in the distribution of benefits from investment incentives, as they overwhelmingly favor foreign companies over small and medium-sized domestic firms.
• The report identifies four critical success factors for biotechnology development: strong public administration and governance, effective institutions, infrastructure development, and clustering.
• To sustain growth, the document recommends that Singapore focus on niche disease areas where it has a comparative advantage due to its multi-ethnic population.
• Regional integration through the ASEAN Investment Area (AIA) is viewed as a key opportunity to expand market access and collaborate on biotechnology R&D for tropical diseases and vaccines.

APA

Lim, H., & Wei, L. T. (2010). Sustainable Development Impacts of Investment Incentives. International Institute for Sustainable Development. https://www.iisd.org/system/files/publications/sd_impacts_singapore.pdf

Chicago

Lim, Hank, and Lim Tai Wei. Sustainable Development Impacts of Investment Incentives. International Institute for Sustainable Development, 2010. https://www.iisd.org/system/files/publications/sd_impacts_singapore.pdf.

Wikipedia

{{cite report |last1=Lim |first1=Hank |last2=Wei |first2=Lim Tai |title=Sustainable Development Impacts of Investment Incentives |publisher=International Institute for Sustainable Development |date=2010 |url=https://www.iisd.org/system/files/publications/sd_impacts_singapore.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{lim2010sustainable, author = {Lim, Hank and Wei, Lim Tai}, title = {{Sustainable Development Impacts of Investment Incentives}}, institution = {International Institute for Sustainable Development}, year = {2010}, url = {https://www.iisd.org/system/files/publications/sd_impacts_singapore.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }